Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely ampicillin trihydrate 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
|
Product containing precisely ampicillin trihydrate 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
|
Ampicillin trihydrate 125mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
|
Ampicillin trihydrate 250mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
|
Product containing precisely ampicillin trihydrate 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
1 |
Product containing precisely ampicillin trihydrate 250 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
1 |
Product containing precisely ampicillin trihydrate 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
1 |
Product containing precisely ampicillin trihydrate 500 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
1 |
Product containing precisely ampicillin trihydrate 500 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
1 |
Product containing precisely ampicillin trihydrate 250 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
1 |
Product containing precisely ampicillin (as ampicillin trihydrate) 25 milligram/1 milliliter and flucloxacillin (as flucloxacillin magnesium) 25 milligram/1 milliliter conventional release oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
2 |
Product containing precisely ampicillin (as ampicillin trihydrate) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ampicillin trihydrate |
Inferred relationship |
Some |
1 |